Idaho2026Active
H0530
Idaho Bill H0530: Rules for Cancer Drug Costs
Last scannedAug 24, 2026, 7:59 AM
In one sentence
This bill sets rules so that health plans in Idaho must either charge the same out-of-pocket costs for oral cancer drugs as they do for injected or IV versions, or limit those costs to $250 per month.
What it does
- Defines anticancer medication as a drug used to kill, slow, or prevent cancer growth given by mouth, injection, or vein.
- Requires health plans covering FDA-approved anticancer drugs to keep out-of-pocket costs for oral versions no higher than those for injected or IV versions.
- Allows an alternative rule where out-of-pocket costs for a 30-day supply of oral anticancer medication cannot exceed $250.
- States that increasing copayments, deductibles, or coinsurance amounts does not count as following these new rules.
- Stating that changing how benefits are classified to avoid these cost limits is also not allowed.
Who it affects
- Health benefit plans operating in Idaho
- People covered by health plans who take anticancer medications
Limits and unknowns
- The bill does not require health plans to classify anticancer medications as a specific type of medical benefit.
- The text only applies if the plan already covers Food and Drug Administration-approved anticancer medications.
- The effective date is set for July 1, 2026.
Plain language
Terms to know
- Anticancer medication
- A drug or biologic used to kill, slow, or prevent the growth of cancerous cells.
- Health benefit plan
- An insurance policy defined in Idaho Code section 41-5903 that covers medical care and drugs.
Official record
Sources
Official summary
Health benefit plans, cancer meds
Official activity
Bill history
- H Bus